• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP
Click for more information
2.63% 3.9¢

TRYPTAMINE THERAPEUTICS LIMITED

Market Cap $47.83M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on the development of an advanced and scalable intravenous-infused psilocin formulation, which can be used in conjunction with psychotherapy to address significant unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. It intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin). Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. The Company is engaged in pursuing Phase II clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders. The Company's pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TYP
TYP - Media & News 		18/01/25 20 8.8K
18/01/25 Last post  ma420 Comments Created with Sketch.  20  Views Created with Sketch.  8.8K 
TYP
Ann: Change of Director's Interest Notice - MD 		16/01/25 0 238
16/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  238 
TYP
Ann: Change of Director's Interest Notice - JC 		16/01/25 0 170
16/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  170 
TYP
Ann: Change of Director's Interest Notice - GJ 		16/01/25 0 157
16/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  157 
TYP
Ann: Change of Director's Interest Notice - CN 		16/01/25 0 156
16/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  156 
TYP
Ann: Notification of cessation of securities - TYP 		16/01/25 0 195
16/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  195 
TYP
Ann: Biotech Showcase 2025 Presentation 		16/01/25 10 2.2K
16/01/25 Last post  ma420 Comments Created with Sketch.  10  Views Created with Sketch.  2.2K 
TYP
Ann: Change of Auditor 		06/01/25 0 374
06/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  374 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice - MD
16 Jan 16:36
 
Change of Director's Interest Notice - JC
16 Jan 16:35
 
Change of Director's Interest Notice - GJ
16 Jan 16:35
 
Change of Director's Interest Notice - CN
16 Jan 16:33
 
Notification of cessation of securities - TYP
16 Jan 16:30
 
Biotech Showcase 2025 Presentation
15 Jan 08:20
 
View More arrow Created with Sketch.

Featured News

NEWS Remote Medical Image Aggregation Proves Successful, Moves to Phase 2
right-arrow Created with Sketch.
NEWS Aussie Broadband Appoints Brian Maher as Group CEO
right-arrow Created with Sketch.
NEWS Drilling Ramp-Up at White Devil Gold Project as Exploration Continues
right-arrow Created with Sketch.
NEWS Fifth Platform Lot testing completed, 4DS advances to next stage
right-arrow Created with Sketch.
NEWS Strong Sales Growth for Travelan Immune Supplement Continues
right-arrow Created with Sketch.
NEWS Maiden Drilling at Trekelano to begin in February 2025
right-arrow Created with Sketch.
(20min delay)
Last
3.9¢ 		Change
0.001(2.63%) 		Mkt cap ! $47.83M
Open High Low Value Volume
3.8¢ 3.9¢ 3.8¢ $7.062K 182.4K

Buyers (Bids)

No. Vol. Price($)
2 206403 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 215000 3
View Market Depth
Last trade - 15.59pm 17/01/2025 (20 minute delay) ?
TYP (ASX) Chart

Top Stories

ASX Market Open: Tech stocks pull US indexes lower, reflected in weak Aussie opening | January 17, 2025

The Australian market is set to open virtually flat today, weighed down by falls on all three US bourses, as major tech stocks were lower
HotCopper Highlights: Your most watched stocks for Week 3, 2025 Good afternoon and welcome back to HotCopper highlights for the third week of the year @ let’s get into it. Raiden Resources was by far the most viewed stock as long-awaited results from its WA lithium drilling campaign turned up a duster. The company expanded the program out of t...
Lynas sales revenues up in Q2 of FY 2025, but lower production fuels share price slump Lynas Rare Earths Ltd has seen its share price drop 5.5% after releasing quarterly activities report in which it noted lower production
Lightning Minerals ready to drill with spodumene confirmed in Brazil Lightning Minerals Ltd has confirmed the presence of spodumene mineralisation through Raman spectrographic analysi
Looking ahead to a year of intriguing investment opportunities The New Year brings renewed energy, exciting opportunities, and the promise of growth. But will the market maintain its upward momentum?

Featured News

NEWS Maiden Drilling at Trekelano to begin in February 2025
right-arrow Created with Sketch.
NEWS Strong Sales Growth for Travelan Immune Supplement Continues
right-arrow Created with Sketch.
NEWS European Approval Granted for Prostate Cancer PET Imaging Agent Illuccix
right-arrow Created with Sketch.
NEWS Drilling Ramp-Up at White Devil Gold Project as Exploration Continues
right-arrow Created with Sketch.
NEWS Fifth Platform Lot testing completed, 4DS advances to next stage
right-arrow Created with Sketch.
NEWS Confirmation of Spodumene and High Lithium Soil Results in Brazil
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.